After two years of significant price rises and few apologies, US consumers are starting to get their revenge on corporate America, even as price pressures ease. This sentiment is also echoed by consumers and some analysts in Australia (where supermarkets are facing criticism, not the food companies) and in Europe for another quarter, as well […]
US consumers push back against corporate price hikes Read More »
Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and Australian economic events. Investment markets and key developments over the past week Share markets mostly rose again over the last week with US, Japanese and Australian
Chinese EV giant BYD is in the process of establishing an international network of plants and distribution facilities to circumvent the steep tariffs planned by the US and the European Union. This expansion is clearly being done with the approval of the Chinese government. The US will impose a 100% tariff on Chinese battery-powered EVs,
BYD’s expansion strategy Read More »
Ian Olson – Managing Director – Pointerra Limited (ASX:3DP) provides end-to-end solutions for processing and analysing the key insights from massive 3D data at a new level of speed and scale.
Pointerra (ASX:3DP) – Webinar Presentation Read More »
The following transcript was AI-generated. Manny Anton: Good morning and welcome to this week’s edition of Winston’s Weekly: Covering all things property. I’m Manny Anton your host for today’s property chat. Winston, as always, welcome back. Winston Sammut: Thank you. Manny Anton: All right, let’s start, like we usually do with with the US markets.
Winston’s Weekly: Outlook for rate cuts Read More »
Oleg Vornik – CEO and Managing Director – DroneShield Limited (ASX:DRO) is a global provider of counter-drone solutions.
DroneShield (ASX:DRO) – Webinar Presentation Read More »
To register for today’s webinar click here. Immutep (ASX:IMM) has announced positive results from Cohort B of the TACTI-003 Phase IIb trial: Eftilagimod alfa (efti) in combination with KEYTRUDA®. The results demonstrate efficacy as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma patients with negative PD-L1 expression. Shares are trading 20.34
Stocks of the Hour: Immutep, Middle Island Resources, Inca Minerals Read More »
Australian shares hit a record high of 7938 points following US deflation data for June, which fueled expectations of impending interest rate cuts by the Federal Reserve. This spurred a shift in investor sentiment towards smaller-cap stocks benefiting from lower rates, reflected in declining US bond yields. Amidst sector-specific movements, Australia’s tech sector saw a
ASX up 0.86% near noon: REITs soars by 2.3% Read More »
Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt, Chief Medical Officer Dr Florian Vogl, and Senior Vice President Strategic Development Christian Mueller present on Immutep’s latest clinical results. Key points:Efti in combination with KEYTRUDA (pembrolizumab) achieved a 35.5% response rate in evaluable patients (N=31), according to RECIST 1.1, among the highest recorded for a
A multi-day rally for the S&P 500 came to an end after cooler-than-expected inflation data for June pushed traders to bet on more interest rate cuts this year. The benchmark index closed down 0.9 per cent on Thursday, ending a seven-day winning streak that had been its longest rally in 2024. The tech-heavy Nasdaq Composite
S&P 500s 7-day rally ends as traders shift to small-cap stocks Read More »
